Powering Possibility

Advancing science to predict, prevent, reverse and cure diseases of the immune system.
Explore our research
Homepage Main - Best Dad
The leaders in the human immune system

You. You drive us forward.

Our mission is to predict, prevent, reverse and cure diseases of the immune system. Our vision--a healthy immune system for everyone. Every person in the world. And we want to connect with you. You who have a disease(s) of the immune system. You who want to use our expertise. You who want to work with us. You who want to learn more. Give more. You who want to amplify who we are and what we do.  
 

Feature - BRI Data Scvelo
RNA Velocity Tregs treated with IL-2 Mutein

Collaborate with us

One of our core values is collaboration. We partner with scientists around the world, sharing our technology, biorepositories and expertise. Work with us to advance science and change lives. 
Learn about our opportunities to collaborate

News

News icon

COVID-19 mRNA Vaccination Does Not Promote Autoantibody Development

Read More

New Study Finds That Germinal Centers Are Regulated by Thymic Stromal Lymphopoietin Signaling in B Cells and T Cells

Learn more ➡
News icon

New Study Finds That Germinal Centers Are Regulated by Thymic Stromal Lymphopoietin Signaling in B Cells and T Cells

Read More
Full-width - BRI Caroline Stefani Imaging Core

Powering Possibility

Your support fuels groundbreaking discoveries and life-changing care. Philanthropy backs researchers who want to ask bold questions and get big answers that will change our understanding of the human immune system.  
Support BRI

Blog Stories

Blog Main Image - 3D Biological Cells Blue
March 29, 2023

Learning How Tregs Keep Your Immune System in Check

The immune system keeps us healthy by maintaining a delicate balance. Every cell has a purpose: Some sound the alarm when they see an invader. Some attack germs that don’t belong. And some patrol the other cells in the immune system to make sure they’re doing their job.
Read Article
Blog Main Image - Clinician Woman Talking Patient Man Senior 2
March 14, 2023

Prediction and Prevention: A New Paradigm in Autoimmune Disease

The FDA recently approved teplizumab, a groundbreaking therapy that signals a paradigm shift in treating not only T1D but all autoimmune diseases.
Read Article
Blog Main Image - Paper DNA Profile People
March 14, 2023

Computer Science Reveals Possible Drug Target for Deadly Childhood Leukemia

Dr. Bolouri is an expert in using computer science to advance biomedical research. Working with Soheil Meshinchi, MD, PhD, and his team at Fred Hutch Cancer Center, they made a recent discovery that may lead to new treatments for certain forms of pediatric acute myeloid leukemia (AML).
Read Article

Immuno-what? Hear the latest from BRI

Keep up to date on our latest research, new clinical trials and exciting publications.